Twist Bioscience Corp
TWST31.850USD
+0.780+2.51%
Fechamento 10/06, 16:00（ET）Cotações atrasadas em 15 min
1.92BValor de mercado
PerdaP/L TTM
Mais detalhes de Twist Bioscience Corp Empresa
Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that specializes in manufacturing synthetic DNA by writing DNA on a silicon chip. The Company leverages its technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation and antibody libraries for drug discovery and development. Its gene products include multiplexed gene fragments, express genes, clonal genes and gene fragments. The Company also manufactures synthetic ribonucleic acid (RNA) as well as antibody proteins. It is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. It makes products for use across many industries, including healthcare, industrial chemicals, agriculture and academic research.
Informações de Twist Bioscience Corp
Código da empresaTWST
Nome da EmpresaTwist Bioscience Corp
Data de listagemOct 31, 2018
CEODr. Emily M. Leproust, Ph.D.
Número de funcionários923
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 31
Endereço681 Gateway Blvd.
CidadeSOUTH SAN FRANCISCO
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal94080
Telefone18007190671
Sitehttps://www.twistbioscience.com/
Código da empresaTWST
Data de listagemOct 31, 2018
CEODr. Emily M. Leproust, Ph.D.
Executivos da empresa Twist Bioscience Corp
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
328.92K
-1.19%
Mr. Patrick John Finn, Ph.D.
Mr. Patrick John Finn, Ph.D.
President, Chief Operating Officer
President, Chief Operating Officer
108.58K
-4.43%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
92.71K
+5.07%
Mr. Dennis Cho
Mr. Dennis Cho
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
48.13K
-1.22%
Ms. Paula Green
Ms. Paula Green
Senior Vice President - Human Resources
Senior Vice President - Human Resources
44.01K
-2.63%
Mr. Nelson C. Chan
Mr. Nelson C. Chan
Independent Director
Independent Director
22.25K
+25.16%
Dr. Melissa A. Starovasnik, Ph.D.
Dr. Melissa A. Starovasnik, Ph.D.
Independent Director
Independent Director
15.81K
+39.44%
Mr. Jan Johannessen
Mr. Jan Johannessen
Independent Director
Independent Director
12.60K
+55.04%
Mr. Adam Laponis
Mr. Adam Laponis
Chief Financial Officer
Chief Financial Officer
7.34K
-11.12%
Mr. Robert Werner
Mr. Robert Werner
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
328.92K
-1.19%
Mr. Patrick John Finn, Ph.D.
Mr. Patrick John Finn, Ph.D.
President, Chief Operating Officer
President, Chief Operating Officer
108.58K
-4.43%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
92.71K
+5.07%
Mr. Dennis Cho
Mr. Dennis Cho
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
48.13K
-1.22%
Ms. Paula Green
Ms. Paula Green
Senior Vice President - Human Resources
Senior Vice President - Human Resources
44.01K
-2.63%
Mr. Nelson C. Chan
Mr. Nelson C. Chan
Independent Director
Independent Director
22.25K
+25.16%
Detalhamento da receita
Moeda: USDAtualizado em: há 7 horas
Moeda: USDAtualizado em: há 7 horas
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
NGS tools
55.28M
57.55%
Synthetic genes
27.68M
28.82%
Antibody discovery
5.61M
5.84%
Oligo pools
5.42M
5.65%
DNA libraries
2.06M
2.14%
Por RegiãoUSD
Nome
Receita
Proporção
Americas
59.39M
61.82%
EMEA
30.74M
32.00%
APAC
5.93M
6.17%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
NGS tools
55.28M
57.55%
Synthetic genes
27.68M
28.82%
Antibody discovery
5.61M
5.84%
Oligo pools
5.42M
5.65%
DNA libraries
2.06M
2.14%
Distribuição de ações
Atualizado em: qua, 20 de ago
Atualizado em: qua, 20 de ago
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
ARK Investment Management LLC
10.60%
The Vanguard Group, Inc.
9.64%
Artisan Partners Limited Partnership
8.38%
BlackRock Institutional Trust Company, N.A.
8.05%
William Blair Investment Management, LLC
6.47%
Outro
56.85%
Investidores
Investidores
Proporção
ARK Investment Management LLC
10.60%
The Vanguard Group, Inc.
9.64%
Artisan Partners Limited Partnership
8.38%
BlackRock Institutional Trust Company, N.A.
8.05%
William Blair Investment Management, LLC
6.47%
Outro
56.85%
Tipos de investidores
Investidores
Proporção
Investment Advisor
59.87%
Investment Advisor/Hedge Fund
36.46%
Hedge Fund
12.53%
Research Firm
5.06%
Individual Investor
1.94%
Pension Fund
1.48%
Bank and Trust
0.41%
Family Office
0.18%
Insurance Company
0.07%
Participação acionária institucional
Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
562
70.01M
115.98%
-1.97M
2025Q2
575
70.44M
116.72%
-302.44K
2025Q1
585
70.23M
117.22%
-1.63M
2024Q4
578
67.47M
113.11%
-8.03M
2024Q3
588
67.80M
115.74%
-8.48M
2024Q2
579
66.59M
114.39%
-10.53M
2024Q1
565
68.18M
117.94%
-8.61M
2023Q4
559
67.81M
117.39%
-11.70M
2023Q3
560
68.09M
118.66%
-11.36M
2023Q2
577
69.42M
121.49%
-5.07M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
ARK Investment Management LLC
6.40M
10.6%
+158.85K
+2.54%
Jun 30, 2025
The Vanguard Group, Inc.
5.82M
9.64%
-36.15K
-0.62%
Jun 30, 2025
Artisan Partners Limited Partnership
5.06M
8.38%
-790.34K
-13.51%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
4.86M
8.05%
+226.25K
+4.89%
Jun 30, 2025
William Blair Investment Management, LLC
3.91M
6.47%
+99.74K
+2.62%
Jun 30, 2025
State Street Global Advisors (US)
2.50M
4.14%
-192.68K
-7.15%
Jun 30, 2025
EdgePoint Investment Group Inc.
2.39M
3.95%
+1.27M
+114.33%
Jun 30, 2025
Amova Asset Management Co., Ltd.
2.30M
3.81%
-116.36K
-4.82%
Jun 30, 2025
Invesco Advisers, Inc.
2.29M
3.8%
-1.04M
-31.23%
Jun 30, 2025
Point72 Asset Management, L.P.
2.16M
3.58%
+725.54K
+50.64%
Jun 30, 2025
Ver Mais
ETFs Relacionados
Atualizado em: há 16 horas
Atualizado em: há 16 horas
Nome
Proporção
ARK Genomic Revolution ETF
5.62%
iShares Genomics Immunology and Healthcare ETF
3.42%
Global X Genomics & Biotechnology ETF
1.81%
WisdomTree BioRevolution Fund
1.65%
ARK Innovation ETF
1.4%
Franklin Genomic Advancements ETF
1.21%
ROBO Global Healthcare Technology & Innovation ETF
1.2%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.54%
SPDR S&P Biotech ETF
0.49%
JPMorgan Fundamental Data Science Small Core ETF
0.34%
Ver Mais
ARK Genomic Revolution ETF
Proporção5.62%
iShares Genomics Immunology and Healthcare ETF
Proporção3.42%
Global X Genomics & Biotechnology ETF
Proporção1.81%
WisdomTree BioRevolution Fund
Proporção1.65%
ARK Innovation ETF
Proporção1.4%
Franklin Genomic Advancements ETF
Proporção1.21%
ROBO Global Healthcare Technology & Innovation ETF
Proporção1.2%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporção0.54%
SPDR S&P Biotech ETF
Proporção0.49%
JPMorgan Fundamental Data Science Small Core ETF
Proporção0.34%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
